Marc Antoine Campeau
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marc Antoine Campeau has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Eve Langelier
Université de Sherbrooke
2 shared publications - Audrey Lortie
Département de génie chimique et biotechnologique, Université de Sherbrooke, Sherbrooke, QC, J1K 2R1, Canada
1 shared publication - Corinne Annette Hoesli
Department of Chemical Engineering, McGill University, 3610 rue University, Montreal, QC, Canada
1 shared publication - Dominic Dubé
Département de Génie Mécanique, Université de Sherbrooke, Sherbrooke, QC, J1K 2R1, Canada
1 shared publication - Gaétan Laroche
Laboratoire d’Ingénierie de Surface, Centre de Recherche sur les Matériaux Avancés, Département de Génie des Mines, de la Métallurgie et des Matériaux, Université Laval, 1065 Avenue de la médecine, Québec G1 V 0A6, Canada
1 shared publication - H. Hassanisaber
Cell-biomaterial Biohybrid Systems, Department of Chemical and Biotechnological Engineering, Université de Sherbrooke, 2500 boul. de l'Université, Sherbrooke, Québec, J1K 2R1, Canada
1 shared publication
Latest Publications
- Open Access
- 9 April 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (21) , e05092
Bifunctional Surfaces With Immobilized Antibodies and Bioactive Peptides Mediate Selective Capture and Proliferation of Endothelial Colony‐Forming Cells
Endothelial colony‐forming cells (ECFCs) are of significant interest in vascular biomaterials engineering and cell‐based therapies for cardiovascular diseases. Efficient isolation and expansion of ECFCs on polymeric surfaces either in vitro or in situ in the case of implants could significantly advance ECFC‐based therapies. We present a novel bifunctional surface modification strategy combining oriented antibodies and extracellular matrix‐derived peptides to selectively capture ECFCs on surfaces and then mediate firm adhesion, spreading and proliferation. Studies were conducted with anti‐CD309 antibodies and custom RGD peptides, previously shown to respectively enable ECFC capture and clonal expansion. To aid in oriented antibody immobilization on surfaces while modulating antibody‐RGD surface concentrations, Fc‐binding peptides and RGD peptides were co‐immobilized on aminated surfaces using click chemistry, followed by affinity‐mediated antibody immobilization. Bifunctional anti‐CD309 + RGD surfaces selectively captured ECFCs from a mixture with peripheral blood mononuclear cells in dynamic conditions. The presence of RGD peptides significantly enhanced cell spreading and proliferation, leading to additive effects on surface coverage under flow. Proof‐of‐concept studies demonstrated successful adaptation to 3D polystyrene microcarriers, showcasing potential scalability for clinical‐grade cell production. The surface modification scheme provides a versatile and clinically translatable platform for advancing ECFC‐based regenerative therapies.
- 9 April 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (21) , e05092
Open AccessBifunctional Surfaces With Immobilized Antibodies and Bioactive Peptides Mediate Selective Capture and Proliferation of Endothelial Colony‐Forming Cells
Endothelial colony‐forming cells (ECFCs) are of significant interest in vascular biomaterials engineering and cell‐based therapies for cardiovascular diseases. Efficient isolation and expansion of ECFCs on polymeric surfaces either in vitro or in situ in the case of implants could significantly advance ECFC‐based therapies. We present a novel bifunctional surface modification strategy combining oriented antibodies and extracellular matrix‐derived peptides to selectively capture ECFCs on surfaces and then mediate firm adhesion, spreading and proliferation. Studies were conducted with anti‐CD309 antibodies and custom RGD peptides, previously shown to respectively enable ECFC capture and clonal expansion. To aid in oriented antibody immobilization on surfaces while modulating antibody‐RGD surface concentrations, Fc‐binding peptides and RGD peptides were co‐immobilized on aminated surfaces using click chemistry, followed by affinity‐mediated antibody immobilization. Bifunctional anti‐CD309 + RGD surfaces selectively captured ECFCs from a mixture with peripheral blood mononuclear cells in dynamic conditions. The presence of RGD peptides significantly enhanced cell spreading and proliferation, leading to additive effects on surface coverage under flow. Proof‐of‐concept studies demonstrated successful adaptation to 3D polystyrene microcarriers, showcasing potential scalability for clinical‐grade cell production. The surface modification scheme provides a versatile and clinically translatable platform for advancing ECFC‐based regenerative therapies.
- 24 May 2019
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 459 (1-2) , 121-130
Empagliflozin restores the integrity of the endothelial glycocalyx in vitro
The antihyperglycemic agent empagliflozin not only improves glycemic control but has also been associated with clinically meaningful reductions in cardiovascular events. Studies have shown that empagliflozin significantly reduces cardiovascular death and heart failure-associated hospitalizations. Given that endothelial dysfunction is closely linked with the pathogenesis of atherosclerotic cardiovascular disease, we hypothesized that the cardiovascular benefits observed with empagliflozin may be a result of its positive impact on the health of the endothelial glycocalyx (GCX), a critical component for the endothelium homeostasis. Human abdominal aortic endothelial cells (HAAECs) were either statically cultured or subjected to a steady wall shear stress of 10 dyne/cm2. Empagliflozin (50 µM, 24 h) restored heparinase III-mediated GCX disruption and the normal mechanotransduction responses in GCX-compromised HAAECs while reducing the attachment of all-trans retinoic acid-transformed NB4 cells to HAAECs. The current body of work suggests that the cardioprotective properties previously reported for empagliflozin may in part be due to the ability of empagliflozin to preserve and restore the structural integrity of the GCX, which in turn helps to maintain vascular health by promoting an anti-inflammatory endothelium, in the presence of a pro-inflammatory environment. Further studies are needed to fully understand the mechanisms underlying the cardiovascular benefits of empagliflozin.
- 24 May 2019
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 459 (1-2) , 121-130
Empagliflozin restores the integrity of the endothelial glycocalyx in vitro
The antihyperglycemic agent empagliflozin not only improves glycemic control but has also been associated with clinically meaningful reductions in cardiovascular events. Studies have shown that empagliflozin significantly reduces cardiovascular death and heart failure-associated hospitalizations. Given that endothelial dysfunction is closely linked with the pathogenesis of atherosclerotic cardiovascular disease, we hypothesized that the cardiovascular benefits observed with empagliflozin may be a result of its positive impact on the health of the endothelial glycocalyx (GCX), a critical component for the endothelium homeostasis. Human abdominal aortic endothelial cells (HAAECs) were either statically cultured or subjected to a steady wall shear stress of 10 dyne/cm2. Empagliflozin (50 µM, 24 h) restored heparinase III-mediated GCX disruption and the normal mechanotransduction responses in GCX-compromised HAAECs while reducing the attachment of all-trans retinoic acid-transformed NB4 cells to HAAECs. The current body of work suggests that the cardioprotective properties previously reported for empagliflozin may in part be due to the ability of empagliflozin to preserve and restore the structural integrity of the GCX, which in turn helps to maintain vascular health by promoting an anti-inflammatory endothelium, in the presence of a pro-inflammatory environment. Further studies are needed to fully understand the mechanisms underlying the cardiovascular benefits of empagliflozin.
- 1 May 2019
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 98, 572-583
The effect of substrate bulk stiffness on focal and fibrillar adhesion formation in human abdominal aortic endothelial cells
- 1 May 2019
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 98, 572-583
The effect of substrate bulk stiffness on focal and fibrillar adhesion formation in human abdominal aortic endothelial cells
- Open Access
- 14 July 2017
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 16 (1) , 1-23
Effect of manufacturing and experimental conditions on the mechanical and surface properties of silicone elastomer scaffolds used in endothelial mechanobiological studies
Mechanobiological studies allow the characterization of cell response to mechanical stresses. Cells need to be supported by a material with properties similar to the physiological environment. Silicone elastomers have been used to produce various in vitro scaffolds of different geometries for endothelial cell studies given its relevant mechanical, optical and surface properties. However, obtaining defined and repeatable properties is a challenge as depending on the different manufacturing and processing steps, mechanical and surface properties may vary significantly between research groups. The impact of different manufacturing and processing methods on the mechanical and surface properties was assessed by measuring the Young’s modulus and the contact angle. Silicone samples were produced using different curing temperatures and processed with different sterilization techniques and hydrophilization conditions. Different curing temperatures were used to obtain materials of different stiffness with a chosen silicone elastomer, i.e. Sylgard 184®. Sterilization by boiling had a tendency to stiffen samples cured at lower temperatures whereas UV and ethanol did not alter the material properties. Hydrophilization using sulphuric acid allowed to decrease surface hydrophobicity, however this effect was lost over time as hydrophobic recovery occurred. Extended contact with water maintained decreased hydrophobicity up to 7 days. Mechanobiological studies require complete cell coverage of the scaffolds used prior to mechanical stresses exposure. Different concentrations of fibronectin and collagen were used to coat the scaffolds and cell seeding density was varied to optimize cell coverage. This study highlights the potential bias introduced by manufacturing and processing conditions needed in the preparation of scaffolds used in mechanobiological studies involving endothelial cells. As manufacturing, processing and cell culture conditions are known to influence cell adhesion and function, they should be more thoroughly assessed by research groups that perform such mechanobiological studies using silicone.
- 14 July 2017
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 16 (1) , 1-23
Open AccessEffect of manufacturing and experimental conditions on the mechanical and surface properties of silicone elastomer scaffolds used in endothelial mechanobiological studies
Mechanobiological studies allow the characterization of cell response to mechanical stresses. Cells need to be supported by a material with properties similar to the physiological environment. Silicone elastomers have been used to produce various in vitro scaffolds of different geometries for endothelial cell studies given its relevant mechanical, optical and surface properties. However, obtaining defined and repeatable properties is a challenge as depending on the different manufacturing and processing steps, mechanical and surface properties may vary significantly between research groups. The impact of different manufacturing and processing methods on the mechanical and surface properties was assessed by measuring the Young’s modulus and the contact angle. Silicone samples were produced using different curing temperatures and processed with different sterilization techniques and hydrophilization conditions. Different curing temperatures were used to obtain materials of different stiffness with a chosen silicone elastomer, i.e. Sylgard 184®. Sterilization by boiling had a tendency to stiffen samples cured at lower temperatures whereas UV and ethanol did not alter the material properties. Hydrophilization using sulphuric acid allowed to decrease surface hydrophobicity, however this effect was lost over time as hydrophobic recovery occurred. Extended contact with water maintained decreased hydrophobicity up to 7 days. Mechanobiological studies require complete cell coverage of the scaffolds used prior to mechanical stresses exposure. Different concentrations of fibronectin and collagen were used to coat the scaffolds and cell seeding density was varied to optimize cell coverage. This study highlights the potential bias introduced by manufacturing and processing conditions needed in the preparation of scaffolds used in mechanobiological studies involving endothelial cells. As manufacturing, processing and cell culture conditions are known to influence cell adhesion and function, they should be more thoroughly assessed by research groups that perform such mechanobiological studies using silicone.